Conversa Health Closes $12M Series B Funding Round

Conversa Health, a Portland, Ore.-based virtual care and communication platform that delivers personalized, automated patient engagement, closed a $12m Series B funding round.


The round, which brought the total raised to date to over $26m, was co-led by Builders VC and Northwell Ventures, with participation from P5 Health Ventures, Nassau Street Ventures and UH Ventures, the venture arm of University Hospitals. Builders VC partner Mark Goldstein has joined the Conversa board of directors.

Conversa enables health systems to virtually engage, monitor and manage patients for chronic care, acute discharge, perioperative, oncology, OBGYN, prevention and wellness, and more. The automated care platform engages patients at high frequency and scale, while triaging to care venues when necessary, optimizing and improving the use of telehealth e-visits, phone calls and in-person consults. Conversa’s suite of COVID-19 Virtual Care Programs is being used by innovative organizations like UCSF Health, Northwell, UNC Health, Prisma Health and University Hospitals to provide symptom checking and triage, provide check-ins with quarantined patients, deliver lab results and screen employees, patients and visitors.

The company is also announcing that Murray Brozinsky has been appointed CEO. West Shell III, Conversa’s co-founder, will remain actively engaged as Executive Chairman. Brozinsky joined Conversa in June 2017 as president and chief strategy officer.



Join the discussion